theyre as close as weve come to the magic pill for weight loss
Wegovy, Saxenda and Zepbound are approved for weight loss in the following individuals: Adults with an initial BMI of 30, defined as obesity Adults with an initial BMI of 27, defined as overweight, with at least one weight-related comorbid condition Weight-related comorbid conditions include high blood pressure, cardiovascular disease (such as coronary artery disease, heart attack or heart failure), high cholesterol, obstructive sleep apnea, type 2 diabetes, fatty liver, GERD/acid reflux, osteoarthritis, urinary incontinence, etc
Pre-visit digital intake forms can speed up this step considerably
Diagnosis codes to assist in identifying baseline hypertension and CVD
Presented by Joo-Yong Hahn
Sculptra builds long-term collagen for structural rejuvenation